OXAPROZIN POTASSIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for oxaprozin potassium and what is the scope of patent protection?
Oxaprozin potassium
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for OXAPROZIN POTASSIUM
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 179 |
| DailyMed Link: | OXAPROZIN POTASSIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OXAPROZIN POTASSIUM
US Patents and Regulatory Information for OXAPROZIN POTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DAYPRO ALTA | oxaprozin potassium | TABLET;ORAL | 020776-001 | Oct 17, 2002 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXAPROZIN POTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | DAYPRO ALTA | oxaprozin potassium | TABLET;ORAL | 020776-001 | Oct 17, 2002 | 6,030,643 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
